The first objective of the study was to evaluate a 4-week inpatient pulmonary rehabilitation program on exercise capacity, health-related quality of life (HRQL) and psychological distress in patients with COPD. The second objective was to investigate the influence of gender, age, disease severity, co-morbidity, anxiety and depression on improved HRQL after rehabilitation. The study comprised 136 consecutive patients from baseline to follow-up with mild-to-severe COPD. Exercise capacity was measured by the 6-min walking distance test, disease severity by spirometric tests, HRQL by The St. George's Respiratory Questionnaire and psychological distress by the The Hospital Anxiety and Depression Scale. Variables on socio-demography and co-morbidity were self-reported. Exercise capacity was improved from baseline to follow-up with a score difference of þ44 metres (p ¼ 000). Except for the activity score, HRQL was significantly improved: a change of -3.5 for the symptom score (p ¼ 014), -3.1 for the total score (p ¼ 003) and a clinical significant change of -4.0 for the impact score (p ¼ 002). The anxiety score did not change significantly after rehabilitation (-0.1, p ¼ 545), though there was a significant reduction of the depression score (-0.8, p ¼ 002) and a 10.4% reduction in the prevalence of possible depression cases (p ¼ 017). Patients with forced expiratory volume in 1 second 50% predicted were 4.2 times more likely to achieve a clinical significant improved HRQL after rehabilitation than patients with forced expiratory volume in 1 second <50% predicted (95% confidence interval [CI] 1.7-10.3, p ¼ 002). A 4-week inpatient rehabilitation program improves HRQL and exercise capacity and reduces depression in COPD patients. Patients with mild or moderate disease are more likely to achieve an improved HRQL after rehabilitation than patients with severe or very severe disease.
Introduction
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality throughout the world. Estimates from the World Health Organisation (WHO) show that in 2001, COPD was the fifth leading cause of death in high-income countries and sixth in nations of low and middle income. 1 COPD is expected to rank fifth as cause of death by 2020 worldwide. 2 COPD is characterized by an airflow limitation that is not fully reversible and is associated with an abnormal inflammatory response of the lungs to noxious particles or gases. 2 The disease is also associated with systemic inflammation and skeletal muscle dysfunction, which may contribute to limiting exercise capacity. 3 When comparing COPD with other chronic diseases, COPD patients have a poorer quality of life in physical function, general health and social function than patients with epilepsy, angina pectoris and rheumatoid arthritis. 4 In addition, studies have shown that the prevalence of anxiety and depression in COPD patients is significantly higher than in the general population. 5, 6 Pulmonary rehabilitation has become an established part of the management of COPD. Longer hospital-based or community-based outpatient rehabilitation programs and shorter, more intensive inpatient rehabilitation programs have both proven to be useful and effective in enhancing physical capacity and health-related quality of life (HRQL) 7, 8 and reducing psychological distress in COPD patients. 9, 10 The degree of physiological and functional impairments may influence the setting in which rehabilitation should occur in COPD patients. Therefore, inpatient rehabilitation is considered best suited and more likely to be beneficial for the most disabled patients, older adults and patients with more severe COPD. 11, 12 Simultaneously, there is a growing consensus that older adults and patients with more severe COPD miss out on opportunities for any kind of rehabilitation, despite expected benefits. 13 This is reflected in the clinical studies dealing with the effectiveness of pulmonary rehabilitation in COPD patients where most studies have been performed in outpatient settings. 14 In addition, only 10% of all pulmonary rehabilitation literature refers to effects obtained in inpatient settings. 15 Although HRQL is frequently used as the main outcome measure when evaluating the effect of rehabilitation in COPD patients, the characteristics of those who benefit most from inpatient rehabilitation are less studied.
Hence, the aims of the present study were Evaluate the effects of a 4-week inpatient pulmonary rehabilitation program on HRQL, exercise capacity and psychological distress in patients with mild-to-very severe COPD. Investigate the influence of gender, age, disease severity, co-morbidity, anxiety and depression on HRQL after rehabilitation.
Methods Ethics
The study was approved by the Regional Committee for Medical Research Ethics, Health Region IV, Norway, and the Parliamentary Commissioner for privacy in research, supervised by the Norwegian Social Science Data Services.
Patients and procedures
Potential participants consisted of consecutive patients with COPD who attended a 4-week inpatient rehabilitation program during the period from March 2007 till December 2007 at one of three rehabilitation centres in central and eastern Norway. Included in the study are male and female patients aged 40þ with COPD stages I-IV, without any present exacerbations. More details about the recruitment of participants are reported elsewhere. 16 The potential participants were given oral and written information about the study a few days after they had attended the rehabilitation centre. The patients who wanted to participate returned the questionnaires and a signed written consent form in a postage-paid envelope to the principal researcher. The baseline data were collected during the first week of the rehabilitation program and the follow-up data were collected a few days before discharge. Parallel data collections were carried out in the rehabilitation centres, only interrupted by the summer holiday.
Pulmonary rehabilitation program
Although the three inpatient rehabilitation centres differ from each other in size, ownership and patient payment, the duration and the vocational content of the rehabilitation programs were fully comparable and in accordance with the European Respiratory Society (ERS) and The American Thoracic Society (ATS) requirements regarding pulmonary rehabilitation. 17 The program timetable was structured as 7.5 hours a day, 5 days per week for 4 weeks, and participation was mandatory. After initial evaluation by a physician, a multidisciplinary team (consisting of physician, nurses, physiotherapists, assistant occupational therapists, social workers and ergonomists) assessed the patient and formulated an individualized rehabilitation plan, including training intensity based on patient's medical condition. The rehabilitation program comprised medical, physical, educational, psychosocial and practical/technical activities, which were organized both as group-based treatment and individual counselling. Activities included in the rehabilitation program and number of group sessions are shown in Table 1 . In addition to group sessions, all centres offered daily social and recreational activities and individual couselling with the multidiciplinary team. Patients were also encouraged to exercise on their own. The exercise facilities were similar in all three centres: fitness room, swimming pool and walking paths.
Measures
Classification of severity and stages of COPD. Lung function, expressed by post-bronchodilator forced expiratory volume in 1 second (FEV 1 ), was assessed by spirometric tests carried out by trained personnel. Classification of severity and COPD stages (I-IV) was carried out in accordance with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Guidelines. 2 Exercise capacity. Exercise capacity was measured at commencement of the rehabilitation program and at discharge by a 6-min walking distance test (6MWD). All tests were conducted indoors, on flat, straight corridors and performed in accordance with published guidelines. 18 The results on the 6MWD were reported in metres: higher 6MWD scores indicate a better result. A change of þ35 metres in 6MWD is considered to represent an important effect in patients with moderate to severe COPD. 19 Assessment of HRQL. The St. George's Respiratory Questionnaire (SGRQ) is a disease-specific instrument designed for measuring HRQL in patients with chronic lung disease. It assesses symptoms, physical functioning and psychosocial impact of COPD. 20, 21 The SGRQ is used worldwide and has been translated into at least 70 languages, including Norwegian. 22 The questionnaire is divided into three domains: a symptom score that measures the frequency and severity of respiratory symptoms, an activity score that measures activities that are limited by breathlessness and an impact score that measures aspects of social functioning and psychosocial disturbances caused by airway disease. 20 The score ranges from 0 to 100 for each domain, and higher values reflect decreased HRQL. The scores for the three domains can be added together to give a total score. A change in score of four units is considered clinically significant. Different studies have shown high degree of validity and reliability for the original version as well as for the Norwegian version. 23, 24 Assessment of anxiety and depression. The Hospital
Anxiety and Depression Scale (HADS) was used to assess the presence of anxiety and depressive symptoms. The HADS was constructed by Zigmond and Snaith in 1983 as a quick way to measure symptoms on depression and generalized anxiety in patients in non-psychiatric hospital clinics. 25 The questionnaire was designed to be used in both inpatient and outpatient settings and is easily self-administered in about 5-10 min. The HADS is a widely used, popular self-report measure that has been translated into many languages and is used in a wide variety of clinical populations. 26 Anxiety (HADS-A) and depression (HADS-D) are assessed as separate components, each with seven items that are rated on a four-point scale: 0 (not present) to 3 (significant symptoms). The scores range from 0 to 21 for anxiety and 0 to 21 for depression. 27 Higher scores indicate more severe symptomatology. Various cut-off points have been used, though Zigmond and Snaith recommend a cut-off score of 8 for both scales to include all possible cases. 25 The validity and reliability of the English version 28 and the Norwegian version 29 has been demonstrated.
Socio-demography and co-morbidity. The questionnaire also contained items about socio-demographic characteristics and on self-reported co-morbidity. Comorbidity was defined as organ-specific diseases in the past 12 months, with 'yes/no' response to different Scoring procedure, calculation methods, item weights and missed items procedure were treated according to recommendations by the authors of the HADS 25 and the SGRQ. 20, 30 
Results
As shown in Figure 1 , 170 of the 253 potential participants responded, a response rate of 67% at baseline. Nine patients were excluded because they had pure asthma or had not filled out the forms, which left 161 eligible patients at baseline. No significant differences were found between responders and nonresponders regarding age, gender or disease severity. Between baseline and follow-up, 25 patients dropped out from the study because of withdrawal, death, discontinued stay or an unknown reason. Drop-outs between baseline and follow-up were excluded from the study, leaving 136 eligible patients at follow-up, a response-rate of 84%. Because of the requirement for complete data between baseline and follow-up, various patients within the sample of 136 were included in the analyses. Baseline characteristics of the study sample are shown in Table 2 : men and women are nearly equally represented (79 men vs. 82 women) and the mean age is 65.0. About one-third of the study sample was diagnosed with moderate, severe or very severe COPD and 77.6% of the participants had 1 to 4 additional diseases. Finally, 86.8% had secondary school or less as their highest level of education.
A comparison between drop-outs and completers from baseline to follow-up showed that significantly more drop-outs had only primary school (70.8% vs. 42.2%, p ¼ 009) and all patients with a university/ college education had completed the study (15.6% vs. 0%, p ¼ 038). There were no differences found between drop-outs and completers in age, gender, COPD stage, co-morbidity, HRQL, anxiety and depression. Scores on exercise capacity, HRQL, anxiety and depression before and after rehabilitation are shown in Table 3 . Exercise capacity was improved after rehabilitation, with a mean score difference of þ44 metres (p ¼ 000). All scores on the SGRQ, except from the activity score, improved significantly from baseline to follow-up, with a change of -3.5 for the symptom score (p ¼ 014), -4.0 for the impact score (p ¼ 002) and -3.1 for the total score (p ¼ 003). The anxiety score did not change significantly after rehabilitation (-0.1, p ¼ 545), though there was a significant reduction of the depression score (-0.8, p ¼ 002). The prevalence of normal and possible HADS anxiety cases (8) did not change significantly from baseline to follow-up, whereas a significant increase of normal depression cases (73.3% to 83.7%) and a corresponding decrease of possible depression cases (26.7% to 16.3%) were identified (p ¼ 017).
The adjusted odds ratio (OR) for the independent influence of each demographic, clinical and psychological variable on the change of SGRQ total score between baseline and follow-up is shown in Table 4 . Patients with mild-to-moderate COPD (FEV 1 50% predicted) were more likely to have a clinically significant improved HRQL after inpatient rehabilitation compared to patients with severe and very severe COPD (FEV 1 < 50% predicted; OR 4.2, 95% confidence interval [CI] 1.7-10.3, p ¼ 002). Gender, age, co-morbidity, anxiety and depression were not significantly associated with a clinically significant improved HRQL from baseline to follow-up.
Since exercise capacity might be associated with HRQL, correlation analyses between scores on the 6MWD test and the SGRQ subscales at follow-up were performed. The results showed no significant correlation with the SGRQ symptom score (.007, p ¼ 944), while there were moderate negative correlations with the activity score -.387 (p ¼ 000), the impact score -.352 (p ¼ 001) and the total score -.356 (p ¼ 001).
Discussion
In the study sample, 59.7% had a FEV 1 < 50% of the predicted value, and thus were suffering from severe or very severe airway obstruction. However, figures for the COPD population in Norway show that only approximately 10% are expected to suffer from severe and very severe COPD. 31 The disease severity of the patients in the present study may reflect the type of patients who are admitted to inpatient rehabilitation centres: those who have severe and very severe COPD. 16 The mean age of the responders (65.0 years) is in accordance with the COPD population: the largest prevalence of COPD in Norway is among people aged between 60 and 74 years. 31 The gender distribution in the study sample, 79 males versus 82 females, may reflect the current prevalence of the disease among men and women in developed countries, which in turn may be due to the changing patterns of tobacco smoking. 2 Regarding education, 86.8% of the responders had primary and secondary school educations, while 13.2% had university or college educations, which is in accordance with the education level for people aged 60 to 66 in the general population in Norway. 32 Hence, the external validity of the data can be regarded as satisfactory.
This short, intensive, inpatient, multidisciplinary, pulmonary rehabilitation program resulted in improvements on HRQL, with a change in SGRQ symptom score close to clinical significance and a clinical relevant change of the impact score. The activity score, however, remained nearly unchanged after rehabilitation. Except for the latter case, these changes are in a similar range as some of the previously reported changes in SGRQ scores after pulmonary rehabilitation 33 and indicate an improved HRQL with relief of symptoms and enhanced psychosocial well-being. Since the SGRQ activity score is related to physical capacity, the lack of improvement from baseline to follow-up suggests that there is perhaps limited possibility for physical performance improvement in this group of COPD patients. Exercise and training are an extensive part of the rehabilitation program in the present study, and one might expect some improvements in daily activities requiring physical capacity. On the other hand, it is possible that the SGRQ fails to detect the functions that are trained in the exercise programs in rehabilitation, and thus not able to measure the patients' physical endurance. The score difference between baseline and follow-up on the 6MWD test may also underpin such an assumption, since the measured improvement in exercise capacity is above the defined, important change of 35 m. Improvement in exercise capacity influences HRQL positively, and the score on the walking test at follow-up correlates negatively with the SGRQ activity, impact and total score, which is in line with previous studies. 34 Our results show a significant reduction of the HADS depression score and in the prevalence of possible depression cases after rehabilitation. These results are in line with previously reported changes in depression after pulmonary rehabilitation, 33, 35, 36 although different cut-off points complicate comparisons. In general, it is not clear which components of a pulmonary rehabilitation program specifically contribute to reduction of psychological distress. 37 However, the components exercise, disease education and psychosocial support in the present rehabilitation program may have contributed, separately or combined to reducing depression. Regarding anxiety, no improvements were seen between baseline and follow-up. Since COPD patients may be particularly susceptible to panic anxiety related to dyspnoea, an essential part of the present rehabilitation program was to learn breathing techniques, relaxation, mucus draining and correct physical activity performance. These components of the rehabilitation program, however, did not seem to reduce the level of anxiety for the COPD patients in the present study. On the other hand, this result could be attributed to the HADS questionnaire measuring general anxiety rather than panic anxiety. 25 After rehabilitation, 41.2% of the patients had achieved an improved HRQL. Our regression model explains 20.5% of the variance in improved HRQL, which shows that patients with mild-to-moderate COPD are more likely to achieve such an improvement rather than patients with severe or very severe COPD. This is an unexpected result because the association between lung function and HRQL is considered to be weak. 38, 39 Since female COPD patients tend to report a lower HRQL than males 40 and the psychological distress in COPD patients is found to be associated with HRQL, 41 one might have expected stronger influence from gender, anxiety and depression in the regression model. Our result, however, suggests that a lung function above a certain level may be crucial in order to deal with symptoms, perform physical activities and reduce the psychosocial strains of the disease. Hence, referral to pulmonary rehabilitation at an early stage of the disease may be necessary in order to achieve such HRQL improvement.
Nearly 60% of the patients in the present study had severe or very severe COPD ( Table 2 ). They showed improvement in HRQL below what is considered clinically significant. Less improvement in this group of patients may be explained by enhanced physical and psychosocial strains of the disease, followed by major limitations in physical performance than in those with minor disease. Despite the absence from clinical improvement, inpatient pulmonary rehabilitation may still be beneficial for patients with severe and very severe COPD. One must keep in mind that even minor improvements in HRQL and exercise capacity may be essential for COPD patients with major disease severity. Since lung function is not usually altered by rehabilitation, our results underpin the need to provide a flexible rehabilitation program that takes into consideration all levels of COPD severity. The program should be adapted to individual needs and functionality quite early in the rehabilitation process to optimally improve HRQL.
Some limitations of the study may be taken into account. First, the participants in the present study were not compared to an untreated control group or an outpatient rehabilitation group. Second, the selection of patients in the present study is not random and is therefore a non-probability study sample. Hence, the results must be interpreted with caution, as they cannot be fully generalized for the entire COPD population. Third, due to lack of pre-and postrehabilitation results from many of the patients on the 6MWD test, the number of eligible patients included in these analyses were relatively small, and therefore a loss of statistical power. Finally, a self-report on comorbidity may challenge the validity of the data due to recall bias.
In conclusion, a multidisciplinary 4-week inpatient rehabilitation program improves HRQL and exercise capacity and reduces depression in COPD patients. Patients with mild or moderate COPD are more likely to achieve an improved HRQL after rehabilitation than patients with severe or very severe COPD.
